Anda belum login :: 23 Nov 2024 12:30 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Gonadotropin-Releasing Hormone Agonist Trigger in Oocyte Donors Co-Treated with a Gonadotropin-Releasing Hormone Antagonist: A Dose-Finding Study
Oleh:
Thi Ngoc Lan Vuong
;
Manh Tuong Ho
;
Tan Duc Ha
;
Huy Tuan Phung
;
Gia Bao Huynh
;
Humaidan, Peter
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 105 no. 02 (Feb. 2016)
,
page 356-363.
Topik:
In Vitro Fertilization
;
Gonadotropin-Releasing Hormone Agonist Trigger
;
Oocyte Donor
;
Dose-Finding
;
Triptorelin
Fulltext:
F02 v105 n2 p356 kelik2016.pdf
(629.03KB)
Ketersediaan
Perpustakaan FK
Nomor Panggil:
F02.K
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Objective: To determine the optimal GnRH agonist dose for triggering of oocyte maturation in oocyte donors. Design: Single-center, randomized, parallel, investigator-blinded trial. Setting: IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam. Patient(s): One hundred sixty-five oocyte donors (aged 18–35 years, body mass index [BMI] <28 kg/m2, antimüllerian hormone level >1.25 ng/mL, and antral follicle count =6). Intervention(s): Ovulation trigger with 0.2, 0.3, or 0.4 mg triptorelin in a GnRH antagonist cycle. Main Outcome Measure(s): The primary end point was number of metaphase II oocytes. Secondary end points were fertilization and cleavage rates, number of embryos and top-quality embryos, steroid levels, ovarian volume, and ongoing pregnancy rate (PR) in recipients. Result(s): There were no significant differences between the triptorelin 0.2, 0.3, and 0.4 mg trigger groups with respect to number of metaphase II oocytes (16.0 ± 8.5, 15.9 ± 7.8, and 14.7 ± 8.4, respectively), embryos (13.2 ± 7.8, 11.7 ± 6.9, 11.8 ± 7.0), and number of top-quality embryos (3.8 ± 2.9, 3.6 ± 3.0, 4.1 ± 3.0). Luteinizing hormone levels at 24 hours and 36 hours after trigger was significantly higher with triptorelin 0.4 mg versus 0.2 mg and 0.3 mg (9.8 ± 7.1 IU/L vs. 7.3 ± 4.1 IU/L and 7.2 ± 3.7 IU/L, respectively; 4.6 ± 3.2 IU/L vs. 3.2 ± 2.3 IU/L and 3.3 ± 2.1 IU/L, respectively. Progesterone level at oocyte pick-up +6 days was significantly higher in the 0.4-mg group (2.2 ± 3.7 ng/ml) versus 0.2 mg (1.1 ± 1.0 ng/ml) and 0.3 mg (1.2 ± 1.6 ng/ml). One patient developed early-onset severe ovarian hyperstimulation syndrome (OHSS). Conclusion(s): No significant differences between triptorelin doses of 0.2, 0.3, and 0.4 mg used for ovulation trigger in oocyte donors were seen with regard to the number of mature oocytes and top-quality embryos.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)